Harrow Health(HROW) - 2025 Q4 - Annual Results

Financial Guidance - Harrow, Inc. reaffirmed its full-year 2025 revenue guidance of between $270 million and $280 million[5] Leadership Appointment - Patrick W. Sullivan was appointed as Chief Commercial Officer, bringing over 25 years of commercial leadership experience[7] Compensation Details - Mr. Sullivan's base salary is set at $425,000 per year, with a target annual bonus opportunity of 40% of base compensation[12] - The company will grant Mr. Sullivan 40,000 restricted stock units (RSUs), with 25,000 RSUs vesting when revenue reaches $230 million in a calendar quarter[12]